Sage View Advisory Group, LLC Novo Nordisk A S Transaction History
Sage View Advisory Group, LLC
- $1.97 Trillion
- Q3 2024
A detailed history of Sage View Advisory Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sage View Advisory Group, LLC holds 8,139 shares of NVO stock, worth $711,104. This represents 0.05% of its overall portfolio holdings.
Number of Shares
8,139
Previous 8,949
9.05%
Holding current value
$711,104
Previous $1.28 Billion
24.13%
% of portfolio
0.05%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,957Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.76 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.26 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.25 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.16 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.07 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $197B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...